Sirt1's systemic protective roles and its promise as a target in antiaging medicine

Translational Research

Volumn 157, Issue 5, 2011, Pages 276-284

  Tang, Bor Luen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; SILENT INFORMATION REGULATOR PROTEIN; SILENT INFORMATION REGULATOR PROTEIN 1; SILENT INFORMATION REGULATOR PROTEIN 2; TRANSCRIPTION FACTOR FOXO; UNCLASSIFIED DRUG;

CANCER INHIBITION; DRUG TARGETING; HEART FAILURE; HEART PROTECTION; HUMAN; LIFESPAN; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RENAL PROTECTION; REVIEW;

EID: 79954494901     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2010.11.006     Document Type: Review

References (141)

1. C.H. Westphal, M.A. Dipp, and L. Guarente A therapeutic role for sirtuins in diseases of aging? Trends Biochem Sci 32 2007 555 560 (Pubitemid 350123051)
2. S. Lavu, O. Boss, P.J. Elliott, and P.D. Lambert Sirtuins-novel therapeutic targets to treat age-associated diseases Nat Rev Drug Discov 7 2008 841 853
3. H.S. Ghosh The anti-aging, metabolism potential of SIRT1 Curr Opin Investig Drugs 9 2008 1095 1102
4. G. Blander, and L. Guarente The Sir2 family of protein deacetylases Annu Rev Biochem 73 2004 417 435 (Pubitemid 39050375)
5. J.M. Denu The Sir 2 family of protein deacetylases Curr Opin Chem Biol 9 2005 431 440
6. K.G. Tanner, J. Landry, R. Sternglanz, and J.M. Denu Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose Proc Natl Acad Sci U S A 97 2000 14178 14182 (Pubitemid 32016550)
7. M.C. Haigis, and L.P. Guarente Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction Genes Dev 20 2006 2913 2921 (Pubitemid 44771725)
8. D.A. Sinclair, and L. Guarente Extrachromosomal rDNA circles-a cause of aging in yeast Cell 91 1997 1033 1042 (Pubitemid 28027835)
9. K.T. Howitz, K.J. Bitterman, and H.Y. Cohen Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 2003 191 196 (Pubitemid 37150899)
10. B. Rogina, and S.L. Helfand Sir2 mediates longevity in the fly through a pathway related to calorie restriction Proc Natl Acad Sci U S A 101 2004 15998 16003 (Pubitemid 39507916)
11. J.G. Wood, B. Rogina, and S. Lavu Sirtuin activators mimic caloric restriction and delay ageing in metazoans Nature 430 2004 686 689 (Pubitemid 39061685)
12. C. Cantó, and J. Auwerx Caloric restriction, SIRT1 and longevity Trends Endocrinol Metab 20 2009 325 331
13. H.A. Tissenbaum, and L. Guarente Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans Nature 410 2001 227 230 (Pubitemid 32216597)
14. H.Y. Cohen, C. Miller, and K.J. Bitterman Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase Science 305 2004 390 392 (Pubitemid 38938153)
15. B.L. Tang, and C.E.L. Chua Is systemic activation of Sirt1 beneficial for ageing-associated metabolic disorders? Biochem Biophys Res Commun 391 2010 6 10
16. V.D. Longo Linking sirtuins, IGF-I signaling, and starvation Exp Gerontol 44 2009 70 74
17. D. Herranz, M. Muñoz-Martin, and M. Cañamero Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer Nature Commun 1 2010 1 8
18. H. Huang, and D.J. Tindall Dynamic FoxO transcription factors J Cell Sci 120 2007 2479 2487 (Pubitemid 47323857)
19. I. van Leeuwen, and S. Lain Sirtuins and p53 Adv Cancer Res 102 2009 171 195
20. A. Salminen, A. Kauppinen, T. Suuronen, and K. Kaarniranta SIRT1 longevity factor suppresses NF-kappaB -driven immune responses: regulation of aging via NF-kappaB acetylation? Bioessays 30 2008 939 942
21. F. Picard, M. Kurtev, and N. Chung Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma Nature 429 2004 771 776 (Pubitemid 38833129)
22. S. Nemoto, M.M. Fergusson, and T. Finkel SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha} J Biol Chem 280 2005 16456 16460 (Pubitemid 40616776)
23. J.T. Rodgers, C. Lerin, and W. Haas Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 Nature 434 2005 113 118 (Pubitemid 40349395)
24. C. Cantó, and J. Auwerx PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure Curr Opin Lipidol 20 2009 98 105
25. M. Sugden, P. Caton, and M. Holness PPAR control: it's SIRTainly as easy as PGC J Endocrinol 204 2009 93 104
26. T. Zhang, and W.L. Kraus SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions Biochim Biophys Acta 1804 2010 1666 1675
27. F. Lan, J.M. Cacicedo, N. Ruderman, and Y. Ido SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation J Biol Chem 283 2008 27628 27635
28. H.S. Ghosh, M. McBurney, and P.D. Robbins SIRT1 negatively regulates the mammalian target of rapamycin PloS One 5 2010 e9199
29. V.D. Longo, and B.K. Kennedy Sirtuins in aging and age-related disease Cell 126 2006 257 268 (Pubitemid 44092970)
30. L. Guarente Sirtuins in aging and disease Cold Spring Harb Symp Quant Biol 72 2007 483 488
31. X. Li, S. Zhang, and G. Blander SIRT1 deacetylates and positively regulates the nuclear receptor LXR Mol Cell 28 2007 91 106 (Pubitemid 47531974)
32. B.J. Wilson, A.M. Tremblay, G. Deblois, G. Sylvain-Drolet, and V. Gigure An acetylation switch modulates the transcriptional activity of estrogen-related receptor alpha Mol Endocrinol 24 2010 1349 1358
33. T. Ikenoue, K. Inoki, B. Zhao, and K.L. Guan PTEN acetylation modulates its interaction with PDZ domain Cancer Res 68 2008 6908 6912
34. J.M. Dai, Z.Y. Wang, D.C. Sun, R.X. Lin, and S.Q. Wang SIRT1 interacts with p73 and suppresses p73-dependent transcriptional activity J Cell Physiol 210 2007 161 166
35. K. Li, A. Casta, and R. Wang Regulation of WRN protein cellular localization and enzymatic activities by SIRT1-mediated deacetylation J Biol Chem 283 2008 7590 7598
36. W. Fan, and J. Luo SIRT1 regulates UV-induced DNA repair through deacetylating XPA Mol Cell 39 2010 247 258
37. Y. Zhang, M. Zhang, and H. Dong Deacetylation of cortactin by SIRT1 promotes cell migration Oncogene 28 2009 445 460
38. Y. Fujita, A. Yamaguchi, and K. Hata Zyxin is a novel interacting partner for SIRT1 BMC Cell Biol 10 2009 6
39. M.C. Haigis, and D.A. Sinclair Mammalian sirtuins: biological insights and disease relevance Annu Rev Pathol 5 2010 253 295
40. G. Donmez, and L. Guarente Aging and disease: connections to sirtuins Aging Cell 9 2010 285 290
41. C.P. Hsu, I. Odewale, R.R. Alcendor, and J. Sadoshima Sirt1 protects the heart from aging and stress Biol Chem 389 2008 221 231 (Pubitemid 351329030)
42. N.M. Borradaile, and J.G. Pickering NAD(+), sirtuins, and cardiovascular disease Curr Pharm Des 15 2009 110 117
43. D. Kim, M.D. Nguyen, and M.M. Dobbin SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis EMBO J 26 2007 3169 3179 (Pubitemid 47057498)
44. B.L. Tang Sirt1's Complex Roles in Neuroprotection Cell Mol Neurobiol 29 2009 1093 1103
45. B.L. Tang, and C.E.L. Chua SIRT1 and neuronal diseases Mol Aspects Med 29 2008 187 200 (Pubitemid 351615154)
46. M. Palls, G. Casadesús, and M.A. Smith Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection Curr Neurovasc Res 6 2009 70 81
47. K.A. Nath The role of Sirt1 in renal rejuvenation and resistance to stress J Clin Invest 120 2010 1026 1028
48. T. Liu, P.Y. Liu, and G.M. Marshall The critical role of the class III histone deacetylase SIRT1 in cancer Cancer Res 69 2009 1702 1705
49. J. Yi, and J. Luo SIRT1 and p53, effect on cancer, senescence and beyond Biochim Biophys Acta 1804 2010 1684 1689
50. J.T. Rodgers, C. Lerin, Z. Gerhart-Hines, and P. Puigserver Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways FEBS Lett 582 2008 46 53 (Pubitemid 350297246)
51. P.J. Elliott, and M. Jirousek Sirtuins: novel targets for metabolic disease Curr Opin Investig Drugs 9 2008 371 378 (Pubitemid 351507663)
52. N. Chaudhary, and P.T. Pfluger Metabolic benefits from Sirt1 and Sirt1 activators Curr Opin Clin Nutr Metab Care 12 2009 431 437
53. J. Yu, and J. Auwerx The role of sirtuins in the control of metabolic homeostasis Ann N Y Acad Sci 1173 Suppl. 1 2009 E10 E19
54. D.J. Lomb, G. Laurent, and M.C. Haigis Sirtuins regulate key aspects of lipid metabolism Biochim Biophys Acta 1804 2010 1652 1657
55. J. Yu, and J. Auwerx Protein deacetylation by SIRT1: an emerging key post-translational modification in metabolic regulation Pharmacol Res 62 2010 35 41
56. N.B. Ruderman, X.J. Xu, and L. Nelson AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab 298 2010 E751 E760
57. M.P. Gillum, D.M. Erion, and G.I. Shulman Sirtuin-1 regulation of mammalian metabolism Trends Mol Med 2010 Oct 21 [Epub ahead of print]
58. M.C. Sugden, P.W. Caton, and M.J. Holness PPAR control: it's SIRTainly as easy as PGC J Endocrinol 204 2010 93 104
59. J. Sakamoto, T. Miura, K. Shimamoto, and Y. Horio Predominant expression of Sir2alpha, an NAD-dependent histone deacetylase, in the embryonic mouse heart and brain FEBS Lett 556 2004 281 286 (Pubitemid 38058593)
60. H.L. Cheng, R. Mostoslavsky, and S. Saito Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice Proc Natl Acad Sci U S A 100 2003 10794 10799 (Pubitemid 37140107)
61. R.R. Alcendor, L.A. Kirshenbaum, S.I. Imai, S.F. Vatner, and J. Sadoshima Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes Circ Res 95 2004 971 980 (Pubitemid 39532327)
62. R.R. Alcendor, S. Gao, and P. Zhai Sirt1 regulates aging and resistance to oxidative stress in the heart Circ Res 100 2007 1512 1521 (Pubitemid 46834764)
63. J.B. Pillai, A. Isbatan, S.I. Imai, and M.P. Gupta Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity J Biol Chem 280 2005 43121 43130 (Pubitemid 43049278)
64. S.B. Rajamohan, V.B. Pillai, and M. Gupta SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1 Mol Cell Biol 29 2009 4116 4129
65. D.K. Das, S. Mukherjee, and D. Ray Resveratrol and red wine, healthy heart and longevity Heart Fail Rev 15 2010 467 477
66. C.J. Chen, W. Yu, and Y.C. Fu Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway Biochem Biophys Res Commun 378 2009 389 393
67. E.D.B. Danz, J. Skramsted, N. Henry, J.A. Bennett, and R.S. Keller Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway Free Radic Biol Med 46 2009 1589 1597
68. M. Sulaiman, M.J. Matta, and N.R. Sunderesan Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy Am J Physiol Heart Circ Physiol 298 2010 H833 H843
69. A. Biala, E. Tauriainen, and A. Siltanen Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes Blood Press 19 2010 196 205
70. M. Tanno, A. Kuno, and T. Yano Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure J Biol Chem 285 2010 8375 8382
71. M. Potente, L. Ghaeni, and D. Baldessari SIRT1 controls endothelial angiogenic functions during vascular growth Genes Dev 21 2007 2644 2658 (Pubitemid 47607673)
72. M. Potente, and S. Dimmeler Emerging roles of SIRT1 in vascular endothelial homeostasis Cell Cycle 7 2008 2117 2122 (Pubitemid 352036236)
73. H. Ota, M. Eto, and S. Ogawa SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis J Atheroscler Thromb 17 2010 431 435
74. I. Mattagajasingh, C.S. Kim, and A. Naqvi SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase Proc Natl Acad Sci U S A 104 2007 14855 14860 (Pubitemid 350003232)
75. Q.J. Zhang, Z. Wang, and H.Z. Chen Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice Cardiovasc Res 80 2008 191 199
76. K. Homma, M. Sone, and D. Taura Sirt1 plays an important role in mediating greater functionality of human ES/iPS-derived vascular endothelial cells Atherosclerosis 212 2010 42 47
77. S. Stein, C. Lohmann, and N. Schäfer SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis Eur Heart J 31 2010 2301 2309
78. Z. Ungvari, Z. Orosz, and A. Rivera Resveratrol increases vascular oxidative stress resistance Am J Physiol Heart Circ Physiol 292 2007 H2417 H2424
79. A. Csiszar, N. Labinskyy, and A. Podlutsky Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations Am J Physiol Heart Circ Physiol 294 2008 H2721 H2735
80. Z. Ungvari, N. Labinskyy, and P. Mukhopadhyay Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells Am J Physiol Heart Circ Physiol 297 2009 H1876 H1881
81. G. Rose, S. Dato, and K. Altomare Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly Exp Gerontol 38 2003 1065 1070 (Pubitemid 37324417)
82. D. Bellizzi, G. Rose, and P. Cavalcante A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages Genomics 85 2005 258 263 (Pubitemid 40164791)
83. N.R. Sundaresan, M. Gupta, and G. Kim Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice J Clin Invest 119 2009 2758 2771
84. V.B. Pillai, N.R. Sundaresan, and G. Kim Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway J Biol Chem 285 2010 3133 3144
85. N.R. Sundaresan, S.A. Samant, V.B. Pillai, S.B. Rajamohan, and M.P. Gupta SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70 Mol Cell Biol 28 2008 6384 6401
86. O. Vakhrusheva, C. Smolka, and P. Gajawada Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice Circ Res 102 2008 703 710 (Pubitemid 351457857)
87. L. Gan, and L. Mucke Paths of convergence: sirtuins in aging and neurodegeneration Neuron 58 2008 10 14 (Pubitemid 351467036)
88. G. Ramadori, C.E. Lee, and A.L. Bookout Brain SIRT1: anatomical distribution and regulation by energy availability J Neurosci 28 2008 9989 9996
89. A. Satoh, C.S. Brace, and G. Ben-Josef SIRT1 promotes the central adaptive response to diet restriction through activation of the dorsomedial and lateral nuclei of the hypothalamus J Neurosci 30 2010 10220 10232
90. D.E. Cohen, A.M. Supinski, M.S. Bonkowski, G. Donmez, and L.P. Guarente Neuronal SIRT1 regulates endocrine and behavioral responses to calorie restriction Genes Dev 23 2009 2812 2817
91. G. Ramadori, T. Fujikawa, and M. Fukuda SIRT1 deacetylase in POMC neurons is required for homeostatic defenses against diet-induced obesity Cell Metab 12 2010 78 87
92. S.M. Zakhary, D. Ayubcha, and J.N. Dileo Distribution analysis of deacetylase SIRT1 in rodent and human nervous systems Anat Rec 293 2010 1024 1032
93. M.E. Giannakou, and L. Partridge The interaction between FOXO and SIRT1: tipping the balance towards survival Trends Cell Biol 14 2004 408 412 (Pubitemid 39092697)
94. J.A. Parker, M. Arango, and S. Abderrahmane Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons Nat Genet 37 2005 349 350
95. T.J. van Ham, K.L. Thijssen, and R.C. Breitling elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging PLoS Genet 4 2008 e1000027
96. J. Chen, Y. Zhou, and S. Mueller-Steiner SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling J Biol Chem 280 2005 40364 40374 (Pubitemid 41779174)
97. J. Wang, L. Ho, and W. Qin Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease FASEB J 19 2005 659 661 (Pubitemid 40471277)
98. W. Qin, M. Chachich, and M. Lane Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus) J Alzheimers Dis 10 2006 417 422
99. S. Pedrini, T.L. Carter, and G. Prendergast Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK PLoS Med 2 2005 e18
100. B.L. Tang Alzheimer's disease: channeling APP to non-amyloidogenic processing Biochem Biophys Res Commun 331 2005 375 378 (Pubitemid 40602647)
101. W. Qin, T. Yang, and L. Ho Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction J Biol Chem 281 2006 21745 21754 (Pubitemid 44181878)
102. G. Donmez, D. Wang, D.E. Cohen, and L. Guarente SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10 Cell 142 2010 320 332
103. Y. Li, W. Xu, M.W. McBurney, and V.D. Longo SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons Cell Metab 8 2008 38 48 (Pubitemid 351859225)
104. B.L. Tang Resveratrol is neuroprotective because it is not a direct activator of Sirt1-A hypothesis Brain Res Bull 81 2010 359 361
105. S. Kume, M. Haneda, and K. Kanasaki Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation Free Radic Biol Med 40 2006 2175 2182 (Pubitemid 43903102)
106. S. Kume, M. Haneda, and K. Kanasaki SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation J Biol Chem 282 2007 151 158 (Pubitemid 47076643)
107. J. Li, X. Qu, S.D. Ricardo, J.F. Bertram, and D.J. Nikolic-Paterson Resveratrol inhibits renal fibrosis in the obstructed kidney. Potential role in deacetylation of Smad3 Am J Pathol 177 2010 1065 1071
108. K. Hasegawa, S. Wakino, and K. Yoshioka Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression Biochem Biophys Res Commun 372 2008 51 56
109. K. Hasegawa, S. Wakino, and K. Yoshioka Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function J Biol Chem 285 2010 13045 13056
110. W. He, Y. Wang, and M.Z. Zhang Sirt1 activation protects the mouse renal medulla from oxidative injury J Clin Invest 120 2010 1056 1068
111. S. Kume, T. Uzu, and K. Horiike Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney J Clin Invest 120 2010 1043 1055
112. W. Mühlberg, and D. Platt Age-dependent changes of the kidneys: pharmacological implications Gerontology 45 1999 243 253 (Pubitemid 29408280)
113. J.P. Kugler, and T. Hustead Hyponatremia and hypernatremia in the elderly Am Fam Physician 61 2000 3623 3630
114. D. Zhang, S. Li, P. Cruz, and B.C. Kone Sirtuin 1 functionally and physically interacts with disruptor of telomeric silencing-1 to regulate alpha-ENaC transcription in collecting duct J Biol Chem 284 2009 20917 20926
115. W. Zhang, X. Xia, and D.I. Jalal Aldosterone-sensitive repression of ENaCalpha transcription by a histone H3 lysine-79 methyltransferase Am J Physiol Cell Physiol 290 2006 C936 C946
116. L.R. Saunders, and E. Verdin Sirtuins: critical regulators at the crossroads between cancer and aging Oncogene 26 2007 5489 5504 (Pubitemid 47255930)
117. W.Y. Chen, D.H. Wang, and R.C. Yen Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses Cell 123 2005 437 448 (Pubitemid 41546674)
118. J.E. Kim, J. Chen, and Z. Lou DBC1 is a negative regulator of SIRT1 Nature 451 2008 583 586 (Pubitemid 351186264)
119. W. Zhao, J.P. Kruse, and Y. Tang Negative regulation of the deacetylase SIRT1 by DBC1 Nature 451 2008 587 590 (Pubitemid 351186268)
120. J.Y. Sung, R. Kim, J.E. Kim, and J. Lee Balance between SIRT1 and DBC1 expression is lost in breast cancer Cancer Sci 101 2010 1738 1744
121. J. Ford, M. Jiang, and J. Milner Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival Cancer Res 65 2005 10457 10463 (Pubitemid 41743740)
122. C.J. Chang, C.C. Hsu, and M.C. Yung Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression Biochem Biophys Res Commun 380 2009 236 242
123. C. Wang, L. Chen, and X. Hou Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage Nat Cell Biol 8 2006 1025 1031 (Pubitemid 44314735)
124. F. Chu, P.M. Chou, X. Zheng, B.L. Mirkin, and A. Rebbaa Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1 Cancer Res 65 2005 10183 10187 (Pubitemid 41743708)
125. F. Yeung, J.E. Hoberg, and C.S. Ramsey Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase EMBO J 23 2004 2369 2380 (Pubitemid 38954844)
126. R. Firestein, G. Blander, and S. Michan The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth PloS One 3 2008 e2020
127. J. Yuan, K. Minter-Dykhouse, and Z. Lou A c-Myc-SIRT1 feedback loop regulates cell growth and transformation J Cell Biol 185 2009 203 211
128. N. Kabra, Z. Li, and L. Chen SirT1 is an inhibitor of proliferation and tumor formation in colon cancer J Biol Chem 284 2009 18210 18217
129. R.H. Wang, K. Sengupta, and C. Li Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice Cancer Cell 14 2008 312 323
130. R.H. Wang, Y. Zheng, and H.S. Kim Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis Mol Cell 32 2008 11 20
131. J.K. Kundu, and Y.J. Surh Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives Cancer Lett 269 2008 243 261
132. M. Athar, J.H. Back, L. Kopelovich, D.R. Bickers, and A.L. Kim Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms Arch Biochem Biophys 486 2009 95 102
133. G. Boily, X.H. He, B. Pearce, K. Jardine, and M.W. McBurney SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol Oncogene 28 2009 2882 2893
134. L. Buday, and J. Downward Roles of cortactin in tumor pathogenesis Biochim Biophys Acta 1775 2007 263 273 (Pubitemid 46899339)
135. G. Ren, M.S. Crampton, and A.S. Yap Cortactin: coordinating adhesion and the actin cytoskeleton at cellular protrusions Cell Motil Cytoskeleton 66 2009 865 873
136. X. Zhang, Z. Yuan, and Y. Zhang HDAC6 modulates cell motility by altering the acetylation level of cortactin Mol Cell 27 2007 197 213 (Pubitemid 47058299)
137. J.A. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat Rev Drug Discov 5 2006 493 506 (Pubitemid 44136961)
138. J.A. Baur, K.J. Pearson, and N.L. Price Resveratrol improves health and survival of mice on a high-calorie diet Nature 444 2006 337 342 (Pubitemid 44764104)
139. K.J. Pearson, J.A. Baur, and K.N. Lewis Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span Cell Metab 8 2008 157 168
140. J.C. Milne, P.D. Lambert, and S. Schenk Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes Nature 450 2007 712 716 (Pubitemid 350207685)
141. E. Lara, A. Mai, and V. Calvanese Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect Oncogene 28 2009 781 791